Literature DB >> 14623098

Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives.

Robert Fredriksson1, Pär J Höglund, David E I Gloriam, Malin C Lagerström, Helgi B Schiöth.   

Abstract

We report seven new members of the superfamily of human G protein-coupled receptors (GPCRs) found by searches in the human genome databases, termed GPR100, GPR119, GPR120, GPR135, GPR136, GPR141, and GPR142. We also report 16 orthologues of these receptors in mouse, rat, fugu (pufferfish) and zebrafish. Phylogenetic analysis shows that these are additional members of the family of rhodopsin-type GPCRs. GPR100 shows similarity with the orphan receptor SALPR. Remarkably, the other receptors do not have any close relative among other known human rhodopsin-like GPCRs. Most of these orphan receptors are highly conserved through several vertebrate species and are present in single copies. Analysis of expressed sequence tag (EST) sequences indicated individual expression patterns, such as for GPR135, which was found in a wide variety of tissues including eye, brain, cervix, stomach and testis. Several ESTs for GPR141 were found in marrow and cancer cells, while the other receptors seem to have more restricted expression patterns.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623098     DOI: 10.1016/s0014-5793(03)01196-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  64 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Differential signaling by splice variants of the human free fatty acid receptor GPR120.

Authors:  Sarah-Jane Watson; Alastair J H Brown; Nicholas D Holliday
Journal:  Mol Pharmacol       Date:  2012-01-26       Impact factor: 4.436

Review 3.  Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders.

Authors:  Yu Chen; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-03-23       Impact factor: 13.820

4.  G protein-coupled receptors and insulin secretion: 119 and counting.

Authors:  S R Murthy Madiraju; Vincent Poitout
Journal:  Endocrinology       Date:  2007-06       Impact factor: 4.736

Review 5.  Is there a fatty acid taste?

Authors:  Richard D Mattes
Journal:  Annu Rev Nutr       Date:  2009       Impact factor: 11.848

Review 6.  Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic, and drug discovery aspects.

Authors:  Stefano Costanzi; Susanne Neumann; Marvin C Gershengorn
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

7.  Gastrointestinal hormonal responses on GPR119 activation in lean and diseased rodent models of type 2 diabetes.

Authors:  S Patel; O J Mace; I R Tough; J White; T-A Cock; U Warpman Berglund; M Schindler; H M Cox
Journal:  Int J Obes (Lond)       Date:  2014-01-23       Impact factor: 5.095

8.  Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT1R Initiated by van der Waals Attraction.

Authors:  Khuraijam Dhanachandra Singh; Hamiyet Unal; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Chem Inf Model       Date:  2019-01-16       Impact factor: 4.956

Review 9.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

10.  Glutamate, aspartate and nucleotide transporters in the SLC17 family form four main phylogenetic clusters: evolution and tissue expression.

Authors:  Smitha Sreedharan; Jafar H A Shaik; Pawel K Olszewski; Allen S Levine; Helgi B Schiöth; Robert Fredriksson
Journal:  BMC Genomics       Date:  2010-01-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.